MSB

2.03%

$1.45 mesoblast limited

banter and General Discussion, page-10161

First 10161 Last

Share
Profile

Follow
Lopez

12,374 Posts.

1106

16/07/24

12:51

Post #: 74773621
Share

Originally posted by JB1975: ↑

No one here and this includes you, know the specific potency assay components.I think I do know them - if I was you I'd assert I do know them - (because that's how you roll) because on the basis of all that I do know from the public domain - I know they had two at ODAC and what they were - I know the patent application and patent granted contents I posted about recently. Same two.

I know they have not said they solved the potency assay problem - and I know Silviu was concerned about it as recently as the start of March this year.

I know they talked of gold standards as though lesser standards in potency assay might be acceptable.

In short I am confident I do know MSBs potency assay - its two parts - its TNFR1 levels and its IL2Ralpha inhibition on co-cultured T cell levels.

And, separately, the above was just rebuttal - saying there is evidence a lot of it in the public domain though you won't see it through eyes clenched shut, I know it must remain as a weak point for two reasons - I understand the science MSB has presented and second I understand MSB has not said they have a validated potency assay or that the FDA said they did - and it would have been a huge deal if they could have said that - previously before CRL # 2 MSB had even claimed they had a validated potency assay - but that was in their opinion - then the FDA disagreed and they couldn't say that anymore.

You like Reg are in denial - he has in his sig line the bottom line is that the cells did work - the bottom line is actually that it isn't clear why the cells from just three donors worked - so its not clear that potency can be assured -so its not clear cells will work - until the potency assay is validated on the science. I'm saying on the science now not on just the FDA's opinion because I have to acknowledge its possible the FDA have slipped up on the science evaluation perhaps if the previous experts are not their or are being overruled - that is the only way I can think of that Silviu's statements about the FDA could be true. And I don't think they are true.

I could not possible care less if you think I am a smarty pants or not - I know I got the call right pre CRL #2 and how and why I did. And this is an easier call than that was - because MSB have not obtained any new data from any new patients (had they done that - they'd have said so) rather they have said the opposite - they've said the re-evaluated old data.

Expand

Hi JB,
Your posts are sillier and sillier.

Stop jamming up the board please.

Aloha

MSB Price at posting: $1.16 Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

SGR

Thousands eye Star on HotCopper, SkyCity in strife – are ASX casino stocks safe anymore?

TYP

Tryptamine psilocin treatment found safe in IV infusion during early stage trial

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

YAL

Yancoal Australia reports strong Q3 financials

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

TLX

Telix Pharmaceuticals' quarterly revenue exceeds AU$200M

ASX Market Open: ASX set for red Friday after flat night in Wall Street | 18 Oct

M4M

Macro and Norden set up transport solutions initiative for West Pilbara

THB

Thunderbird picks up plethora of uranium targets based on EM survey in Canada

There are more pages in this discussion • 1,655 more messages in this thread...

First 10161 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.45		Change -0.030(2.03%)		Mkt cap ! $1.655B

Open	High	Low	Value	Volume
$1.48	$1.51	$1.43	$6.613M	4.498M

Buyers (Bids)

No.	Vol.	Price($)
1	2482	$1.45

Sellers (Offers)

Price($)	Vol.	No.
$1.46	27045	2

View Market Depth

No.	Vol.	Price($)
1	2482	1.450
2	5794	1.445
6	50901	1.440
4	52442	1.435
5	177906	1.430

Price($)	Vol.	No.
1.455	27045	2
1.460	64331	5
1.465	35901	2
1.470	54504	2
1.480	132521	3

Last trade - 16.10pm 18/10/2024 (20 minute delay)

MSB (ASX) Chart

banter and General Discussion, page-10161

Thousands eye Star on HotCopper, SkyCity in strife – are ASX casino stocks safe anymore?

Tryptamine psilocin treatment found safe in IV infusion during early stage trial

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Yancoal Australia reports strong Q3 financials

Talga Group wins key permit for flagship graphite mine in Sweden

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

Telix Pharmaceuticals' quarterly revenue exceeds AU$200M

ASX Market Open: ASX set for red Friday after flat night in Wall Street | 18 Oct

Macro and Norden set up transport solutions initiative for West Pilbara

Thunderbird picks up plethora of uranium targets based on EM survey in Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

banter and General Discussion, page-10161

Top Stories

Thousands eye Star on HotCopper, SkyCity in strife – are ASX casino stocks safe anymore?

Tryptamine psilocin treatment found safe in IV infusion during early stage trial

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Yancoal Australia reports strong Q3 financials

Talga Group wins key permit for flagship graphite mine in Sweden

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

Telix Pharmaceuticals' quarterly revenue exceeds AU$200M

ASX Market Open: ASX set for red Friday after flat night in Wall Street | 18 Oct

Macro and Norden set up transport solutions initiative for West Pilbara

Thunderbird picks up plethora of uranium targets based on EM survey in Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News